Swine Flu Vaccinations Could Be Risky
Health and Human Services Secretary Kathleen Sebelius advocates a massive H1N1 vaccination program for schoolchildren this fall, putting schools on notice that they might be turned into shot clinics.
“If you think about vaccinating kids, schools are the logical place,” Sebelius said in June.
No decision has been made yet on whether and how to vaccinate millions of Americans against the new flu strain that the World Health Organization formally declared a pandemic.
While swine flu doesn’t yet seem any more lethal than the regular flu that each winter kills 36,000 people in the U.S. alone, scientists fear it may morph into a more dangerous type. Even in its current form, the WHO says about half of the more than 160 people worldwide killed by swine flu so far were previously young and healthy.
If that trend continues, “the target may be school-age children as a first priority” for vaccination, Sebelius said. “That’s being watched carefully.”
However, some experts warn that the benefits of the H1N1 vaccine may not outweigh the risks. At least two of the drug companies with US government contracts to produce the swine flu vaccine contain squalene oil as an adjuvant.
Micropaleontologist Dr. Viera Scheibner conducted research into the adverse effects of adjuvants in vaccines and wrote:
Squalene “contributed to the cascade of reactions called “ Gulf War syndrome. GIs developed arthritis, fibromyalgia, lymphadenopathy, rashes, photosensitive rashes, malar rashes, chronic fatigue, chronic headaches, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated ESR (erythrocyte sedimentation rate), systemic lupus erythematosus, multiple sclerosis, deadly Amyotrophic Lateral Sclerosis, Raynaud’s phenomenon with paroxysms of lack of blood in fingers and toes in fingers and toes, Sjorgren’s syndrome with blurred vision, chronic diarrhea, night sweats and low-grade fever.”
According to Meryl Nass, M.D., an authority on the anthrax vaccine, “A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”
Several other studies have been conducted that link squalene, as an experimental vaccine adjuvant, to autoimmune disorders like those seen in Gulf War Syndrome.
Vaccine makers and federal officials will be immune from lawsuits that result from any new swine flu vaccine, under a document signed by Secretary of Health and Human Services Kathleen Sebelius, according to government health officials.
NOT ME OR MY KIDS!!!!!!!!!